RxDoctor Payments Data

David Gutierrez, MD

Pain Medicine · New Haven, CTNPI 1760828172

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. SPR Therapeutics, Inc accounts for 83.6% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $75,842, more than ten times the $1,333 reported in 2020. Among pain medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$151,334in general payments, 2019–2025

Across 407 payments — averaging $371.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$127K
  • Boston Scientific$20K
  • Relievant Medsystems, Inc.$2K
  • Saluda Medical Americas, Inc.$1K
  • Medtronic$294
  • Nalu Medical, Inc.$187
  • plus $956 from 13 others

What the payments were for

  • Consulting fees$74,08949%
  • Speaking & faculty fees$13,7009%
  • Travel & lodging$51,01834%
  • Food & beverage$12,5278%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$151,334 in reported general payments places this provider in the 95th percentile of 69 pain medicine providers in Connecticut.

See all pain medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$94,862
Medicare patients
274
Services billed
755

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate16$15,915
Pregabalin57$1,668
Morphine Sulfate ErMorphine Sulfate12$1,369
Lidocaine13$838
Gabapentin61$827
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen78$666
Baclofen44$631
Morphine Sulfate22$601
Tizanidine Hcl39$516
Methocarbamol21$506
Oxycodone Hcl32$387
Tramadol Hcl75$309
Diclofenac Sodium14$292
Cyclobenzaprine Hcl12$214
Methylprednisolone22$135

Paid to pharmacies, not to this prescriber.

Other pain medicine in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →